- Original research article
- Open access
- Published:
Experience in the management of sigmoid sinus thrombophlebitis secondary to middle ear cholesteatoma
Journal of Otolaryngology - Head & Neck Surgery volume 52, Article number: 84 (2023)
Abstract
Objective
To discuss the management of sigmoid sinus thrombophlebitis secondary to middle ear cholesteatoma.
Methods
We retrospectively analyzed all cases of sigmoid sinus thrombophlebitis caused by middle ear cholesteatoma over a period of 7 years. 7 male and 2 female patients, ranging in age from 9 to 66 years, were diagnosed with sigmoid sinus thrombophlebitis by clinical presentation and radiological examination. By executing a modified mastoidectomy and tympanoplasty (canal wall-down tympanoplasty) to entirely remove the cholesteatoma-like mastoid epithelium, all patients were effectively treated surgically without opening the sigmoid sinus. All patients were treated with broad-spectrum antibiotics, but no anticoagulants were used.
Results
9 patients had otogenic symptoms such as ear pus, tympanic membrane perforation, and hearing loss. In the initial stage of the surgery, modified mastoidectomy and tympanoplasty were performed on 8 of the 9 patients. 1 patient with a brain abscess underwent puncturing (drainage of the abscess) to relieve cranial pressure, and 4 months later, a modified mastoidectomy and tympanoplasty were carried out. Following surgery and medication, the clinical symptoms of every patient improved. After the follow-up of 6 months to 7 years, 3 patients were re-examined for MRV and showed partial sigmoid sinus recovery with recanalization. 4 months following middle ear surgery, the extent of a patient's brain abscess lesions was significantly reduced. 1 patient experienced facial paralysis after surgery and recovered in 3 months. None of the patients had a secondary illness, an infection, or an abscess in a distant organ.
Conclusion
The key to a better prognosis is an adequate course of perioperative antibiotic medication coupled with surgical treatment. A stable sigmoid sinus thrombus can remain for a long time after middle ear lesions have been removed, and it is less likely to cause infection and abscesses in the distant organs. The restoration of middle ear ventilation is facilitated by tympanoplasty. It is important to work more closely with multidisciplinary teams such as neurology and neurosurgery when deciding whether to perform lateral sinusotomies to remove thrombus or whether to administer anticoagulation.
Graphical abstract
Background
The mortality rate of sigmoid sinus thrombophlebitis is as high as 5%-10% [1,2,3]. Fever, headaches, edema of the optic papillae, and ear symptoms such as earaches, pus, hearing loss, and swelling or pain in the mastoid process are frequently observed in the early stages of the disease [4]. The uncontrolled use of antibiotics frequently masks these symptoms. There is still debate regarding the surgical treatments for otogenic sigmoid sinus thrombophlebitis, including sigmoid sinus exploration, incision of the sinus wall to remove the embolus, and sigmoid sinus ligation [1, 5]. By reviewing the clinical information of 9 patients with otogenic sigmoid sinus thrombophlebitis who were admitted to our hospital and combining it with relevant literature, we hope to assist readers in choosing an appropriate diagnosis and treatment strategy for this disease.
Methods
The clinical data of all the patients diagnosed with otogenic sigmoid sinus thrombophlebitis in the Department of Otorhinolaryngology-Head and Neck Surgery of the Affiliated Hospital of Southwest Medical University between 2015 and 2022 were retrospectively analyzed. The prognosis of the patients was evaluated by follow-up imaging data and telephone interviews.
Results
The 9 cases ranged in age from 9 to 66, with a duration of 2 months to 40 years. Of the 9, 7 were male and 2 were female. At the time of admission, there were 4 cases with febrile symptoms (Patients 2, 5, 7, 8), 5 cases with headache (Patients 2, 3, 5, 7, 8), 2 cases with vertigo (Patients 3, 8) and 3 cases with earache (Patients 2, 7, 9). All the patients had purulent ear leakage, including 3 with vomiting (Patients 2, 7, 8). During the course of the illness, there were 2 cases of impaired awareness (Patients 2 and 3), 1 case of optic papilla edema (Patient 3), and 1 case of diplopia (Patient 3) (Table 1).
Radiologic and laboratory findings
The temporal bone computed tomography (CT) in all patients showed middle ear abnormalities and varying degrees of bone destruction and defects between the bone wall of the sigmoid sinus and the mastoid cavity (Fig. 1a). Except for patient 2, whose enhanced magnetic resonance imaging (MRI) suggested the possibility of thrombus formation in the sigmoid and transverse sinuses, none of the patients' cranial MRIs revealed any apparent evidence of thrombus. The extent of the temporal lobe brain abscess was visible on patient 3's MRI (Fig. 1d). Before surgery, 8 patients received MRV examinations (Fig. 1b). Of these, 3 cases involved only the sigmoid sinus, 4 cases involved both the sigmoid and transverse sinuses, and 1 case involved the transverse, sigmoid, and superior sagittal sinuses (Table 2).
Among the 9 patients, 5 had elevated leukocytes, 3 had anemia, and none had thrombocytosis. Bacterial cultures were taken from the external auditory canal secretions, and there were 3 positive results for Enterococcus cotton candy, Serratia marcescens, and Staph epidermidis. Blood cultures were positive in 2 cases. In one case, Enterococcus faecalis and Prevotella regia were both cultured and in another, only Enterococcus cotton candy was cultured. Streptococcus chimera was detected in the retroauricular subperiosteal abscess puncture fluid culture of 1 case (Table 3). A postoperative lumbar puncture was performed on 1 patient (Patient 2) who had normal intracranial pressure, and no obvious abnormalities were found in the cerebrospinal fluid biochemistry or culture.
Treatment
Anti-infective medication was administered to all the patients. The usage of antibiotics lasted an average of 23 days (15–39 days). Tertiary cephalosporins were most frequently utilized, sometimes in combination with ornidazole in serious infections. All medications were given intravenously while the patient was hospitalized. The patients were often instructed to take it orally for at least 7 to 14 days after being discharged (Table 3).
All 9 patients experienced 1 to 2 temporal bone complications, including 2 cases of retroauricular subperiosteal abscess, 1 case of peripheral facial paralysis (House-Brackmann grade II) following surgery, which improved to grade I after three months, and 4 cases of labyrinthine fistulae. Of the 4 cases, the horizontal semicircular canal, the superior semicircular canal, and the posterior semicircular canal were all invaded in 1 case, while only the horizontal semicircular canal was involved in 2 cases, and the posterior semicircular canal was involved in 1 case. There was 1 patient who had a brain abscess in combination. Due to its obvious intracranial occupying effect, external drainage of brain abscess by puncture was performed in neurosurgery at stage I. The patient's symptoms, such as headache, nausea, and vomiting, improved after the operation. A modified mastoidectomy and type III tympanoplasty were carried out after a follow-up of MRI 4 months later, revealing a substantially reduced but still present brain abscess. The remaining 8 patients had tympanoplasty, auditory chain repair, and modified mastoidectomy in stage I(Table 3). No sigmoid sinus puncture, sigmoid sinus ligation, embolization incision, or anticoagulation during the perioperative period was performed on any of the patients.
In 1 of the 4 patients with fever, the temperature returned to normal after switching from ceftizoxime to ceftriaxone based on the drug sensitivity findings before surgery, and in the other 3 patients, the temperature did so within a day after the operation. All the patients who underwent surgery had satisfactory mastoid cavity epithelialization, and the transplanted fascia lasted after six months to seven years of follow-up (Fig. 2). A postoperative CT revealed that the middle ear cavity had restored its ventilatory function and that there had been no cholesteatoma recurrence (Fig. 3b, d). 7 patients showed no discernible change from the preoperative period, whereas 2 patients demonstrated improvement in hearing compared to the preoperative period. Repeat MRV indicated that the sigmoid sinus resumed recanalization in 1 patient, partial recanalization in 2 patients (Fig. 1c), and stable thrombus formation in the 6 patients who showed no significant change from the preoperative control. None of the 9 patients developed an infection or an abscess that was distant from their organs.
Discussion
The infective symptoms of sigmoid sinus thrombophlebitis described in the current literature may not be typical [6]. In our cases, all the individuals exhibited ear leaks, however, only 5 of 9 also had headaches or fevers. There were 2 patients (Patients 2 and 3) with impaired consciousness, in contrast to the symptoms noted by Mete Iseri, Ireneusz, et al. [7,8,9]. All of our patients were primarily defined by ear symptoms, with minimal cranial nerve involvement. Optic papillary edema was only present in 1 patient with a combined brain abscess, which may be connected to the early use of antibiotics.
Various studies have supported the link between sigmoid sinus thrombophlebitis and various temporal bone complications [10]. All the patients had 1 to 2 temporal bone complications, and meningitis was the most frequent intracranial comorbidity. In contrast to individuals with combined brain abscesses, this group of patients frequently displayed varying fever and headache. The signs and symptoms of temporal bone complications might sometimes be subtle in an era where antibiotic use is common. Therefore, when treating patients with sigmoid sinus thrombophlebitis, otolaryngology experts must be vigilant in identifying other temporal bone problems.
For sigmoid sinus thrombophlebitis, the standard imaging method is the temporal bone CT. It displays the extent of the primary lesion in the middle ear as well as the level of bone erosion in the sigmoid sinus' anterior wall [10]. The anomalies of MRI's presentation have extremely high tissue resolution and sensitivity to blood flow and depend on when thrombosis occurs. T1-weighted images exhibit significant signals in the subacute phase (1–2 weeks) [11]. However, due to the progressive mechanization of the thrombus in patients with a duration of longer than two weeks, MRI frequently fails to demonstrate thrombosis. Only Patient 2's increased MRI raised the likelihood of sigmoid sinus and transverse sinus thrombosis in this group; the preoperative MRI results for the other patients did not raise any such concerns. Patient 5 is one example of a diagnosis that would have been missed if we simply used temporal bone CT and cranial MRI. The anterior wall of the sigmoid sinus did not appear to have any clear areas of bone degradation on the temporal bone CT scan, and neither did the scan on the MRI. However, the patient's preoperative MRV indicated that the sigmoid sinus was thin, and during surgery, the front wall of the sigmoid sinus had a bone defect of approximately 1 × 2 cm2. Additionally, this patient experienced typical sigmoid sinus thrombophlebitis symptoms such as headache, hyperthermia, and sepsis. Compared with conventional MRI, MRV can confirm cerebral venous sinus thrombosis and clarify the extent of thrombus, site of occurrence, and degree of stenosis. Additionally, recanalization of blood arteries following therapy can be seen by MRV, which can increase the accuracy of the diagnosis [1, 10, 11]. It is a crucial adjunct technique for detecting cerebral venous sinus thrombosis.
It is unclear how long sigmoid sinus thrombophlebitis patients will need to take antibiotics. Our cases had an average duration of antibiotic usage of 27 days, which included at least 1 week of home antibiotics, which is largely in line with the literature [12]. Due to the widespread usage of antibiotics, the bacterial culture positivity was only moderate. Although we grew 3 g-positive and 3 g-negative bacteria, most researchers [13] found that gram-negative bacteria were more prevalent. 2 of the 9 cases had mixed flora infections, which are frequently present in patients with sigmoid sinus thrombophlebitis. As a result, we frequently choose antibiotics that have a broad spectrum and are simple to cross the blood–brain barrier. The bacterial culture sensitivity test and clinical symptoms should be taken into account when determining the extent of antibiotic treatment.
Surgery is frequently the mainstay of treatment for otogenic sigmoid sinus thrombophlebitis. Depending on whether the sigmoid sinus is incised for embolization, it is classified as conservative or radical [14]. According to certain research, radical surgical operations such as jugular vein ligation or phlebotomy for thrombolysis should only be undertaken if infectious thromboembolic features are unmistakably progressing [15, 16]. Internal jugular vein ligation and incisions for thrombolysis were both shown to be ineffective in the treatment of individuals with sigmoid sinus thrombophlebitis, according to Thorsten et al.'s retrospective analysis of 6 patients with sigmoid sinus thrombophlebitis [17]. In our group, only otologic surgery was conducted on all 9 patients because there were no clear progressing indications of infective thrombus (Figs. 2 and 3). All 9 patients had a good prognosis and positive postoperative results. None of them showed infection or thrombus dislodging away from the organ. Therefore, we advise against performing invasive procedures such as lateral sinusotomy for thrombus removal or ligation in cases when there are no overt signs of an infective thrombus.
We think that modified mastoidectomy and tympanoplasty in stage I should be carried out as soon as possible in cases with sigmoid sinus thrombophlebitis secondary to middle ear cholesteatoma. The Trautmann method enables removal of the abnormal tissues from the middle ear and appropriate exposure of the surgical cavity. When the cholesteatoma epithelium and inflammatory granulation tissues were present in the damaged vein wall, only the outer membrane of the cholesteatoma was also removed. Using cartilage from the auricular nail cavity, type III tympanoplasty was performed in every patient in our group in stage I (Fig. 4c). Tympanoplasty staging is a subject of debate. When there are serious mucosal lesions, according to James et al. [18], tympanoplasty staging is necessary. According to Luca et al. [19], tympanoplasty in stage II has a recurrence incidence of up to 70%, however, opting for tympanoplasty in stage I nearly eliminates recurrence and lowers the need for hospitalizations and procedures. This approach is affordable and successful. Therefore, we think that tympanoplasty and modified mastoidectomy should be carried out as soon as possible. The key to treating this condition, particularly the sick tissue surrounding the eustachian tube aperture, is to completely remove the middle ear infective lesions. This is crucial for enhancing the hearing prognosis and aiding in restoring the middle ear's ability to hold air following tympanoplasty [20].
The role of anticoagulation therapy for sigmoid sinus thrombophlebitis is unclear. Six sigmoid sinus thrombophlebitis patients were included in the analysis by N. de Oliveira Penid et al. [21], 3 of whom received anticoagulation therapy and 3 of whom did not. 1 patient who was not taking anticoagulants and underwent follow-up testing experienced sigmoid sinus recanalization, indicating that the use of anticoagulants is not a factor in this condition. Anticoagulants have the risk of causing thrombocytopenia, worsening operating cavity bleeding, and encouraging the production of septic emboli. We did not administer anticoagulation, which is in keeping with many recommendations in the literature, because there were no evident signs of thrombosis in our case, the infection was swiftly under control following middle ear surgery, and the temperatures all quickly returned to normal range. In our opinion, anticoagulation should be performed only in those with persistent fever despite appropriate surgical intervention, extensive thrombus involvement or cerebral venous infarction, pulmonary embolism, or persistent sepsis [22], and the dosage and intensity of anticoagulation should be guided by a neurologist.
Conclusion
In conclusion, we think that a combination of the patient's medical history, neurologic and otogenic symptoms, signs, and radiographic imaging should be used to make the diagnosis of sigmoid sinus thrombophlebitis secondary to middle ear cholesteatoma. MRV is the most important and intuitive means of recognizing and diagnosing sigmoid sinus thrombophlebitis and adopting the appropriate treatment plan. Based on drug sensitivity tests, enough antibiotics that may cross the blood–brain barrier are employed to treat sigmoid sinus thrombophlebitis secondary to middle ear cholesteatoma. An adequate quantity of blood–brain barrier-crossing antibiotics should be chosen for the treatment of sigmoid sinus thrombophlebitis based on the results of the drug sensitivity test. Along with effective anti-infection measures, a mastoidectomy should be carried out as soon as possible. After the middle ear lesions have been completely removed, tympanoplasty can be performed in stage I, which helps restore the middle ear's ventilation function. When deciding whether to perform lateral sinus incision and embolization ligation and whether to employ anticoagulant therapy, collaboration with interdisciplinary teams such as neurology should be reinforced.
Availability of data and materials
The datasets generated and analyzed during the current study are not publicly available but are available from the corresponding author at reasonable request.
References
Zanoletti E, Cazzador D, Faccioli C, et al. Intracranial venous sinus thrombosis as a complication of otitis media in children: Critical review of diagnosis and management. Int J Pediatr Otorhinolaryngol. 2015;79(12):2398–403. https://doi.org/10.1016/j.ijporl.2015.10.059.
Garcia RD, Baker AS, Cunningham MJ, et al. Sigmoid sinus thrombophlebitis associated with otitis media and mastoiditis in children. Pediatr Infect Dis J. 1995;14(7):617–23. https://doi.org/10.1097/00006454-199507000-00013.
Bales CB, Sobol S, Wetmore R, et al. Sigmoid sinus thrombophlebitis as a complication of otitis media: 10-year experience at the children’s Hospital of Philadelphia. Pediatrics. 2009;123(2):709–13. https://doi.org/10.1542/peds.2008-0280.
Au JK, Adam SI, Michaelides EM. Contemporary management of pediatric sigmoid sinus thrombophlebitis: a twenty-year review. Am J Otolaryngol. 2013;34(2):145–50. https://doi.org/10.1016/j.amjoto.2012.09.011.
Singh GB, Rai AK, Singh S, et al. Management of otogenic sigmoid sinus thrombophlebitis. Auris Nasus Larynx. 2014;41(2):143–7. https://doi.org/10.1016/j.anl.2013.10.005.
Iseri M, Aydin O, Ustündağ E, et al. Management of sigmoid sinus thrombophlebitis in chronic otitis media. Otol Neurotol. 2006;27(8):1098–103. https://doi.org/10.1097/01.mao.0000232002.62997.f3.
Bielecki I, Cofała M, Mierzwiński J. Otogenic sigmoid sinus thrombophlebitis in children. Otol Neurotol. 2011;32(7):1111–5. https://doi.org/10.1097/MAO.0b013e3182267eea.
Dubey SP, Larawin V. Complications of chronic suppurative otitis media and their management. Laryngoscope. 2007;117(2):264–7. https://doi.org/10.1097/01.mlg.0000249728.48588.22.
Syms MJ, Tsai PD, Holtel MR. Management of sigmoid sinus thrombophlebitis. Laryngoscope. 1999;109(10):1616–20. https://doi.org/10.1097/00005537-199910000-00013.
Connor SE, Jarosz JM. Magnetic resonance imaging of cerebral venous sinus thrombosis. Clin Radiol. 2002;57(6):449–61. https://doi.org/10.1053/crad.2001.0880.
Davison SP, Facer GW, McGough PF, et al. Use of magnetic resonance imaging and magnetic resonance angiography in diagnosis of sigmoid sinus thrombosis. Ear Nose Throat J. 1997;76(7):436–41.
Bales CB, Sobol S, Wetmore R, et al. Lateral sinus thrombosis as a complication of otitis media: 10-year experience at the Children’s Hospital of Philadelphia. Pediatrics. 2009;123(2):709–13. https://doi.org/10.1542/peds.2008-0280.
Wanna GB, Dharamsi LM, Moss JR, et al. Contemporary management of intracranial complications of otitis media. Otol Neurotol. 2010;31(1):111–7. https://doi.org/10.1097/MAO.0b013e3181c2a0a8.
Leach JL, Fortuna RB, Jones BV, et al. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics. 2006;26(Suppl 1):S19–43. https://doi.org/10.1148/rg.26si055174.
PenidoNde O, Borin A, Iha LC, et al. Intracranial complications of otitis media: 15 years of experience in 33 patients. Otolaryngol Head Neck Surg. 2005;132(1):37–42. https://doi.org/10.1016/j.otohns.2004.08.007.
Funamura JL, Nguyen AT, Diaz RC. Otogenic sigmoid sinus thrombophlebitis: case series and controversies. Int J Pediatr Otorhinolaryngol. 2014;78(5):866–70. https://doi.org/10.1016/j.ijporl.2014.03.002.
Ropposch T, Nemetz U, Braun EM, et al. Management of otogenic sigmoid sinus thrombosis. Otol Neurotol. 2011;32(7):1120–3. https://doi.org/10.1097/MAO.0b013e31822a1ec0.
Sheehy JL, Shelton C. Tympanoplasty: to stage or not to stage. Otolaryngol Head Neck Surg. 1991;104(3):399–407. https://doi.org/10.1177/019459989110400320.
de Zinis LO, Tonni D, Barezzani MG. Single-stage canal wall-down tympanoplasty: long-term results and prognostic factors. Ann Otol Rhinol Laryngol. 2010;119(5):304–12. https://doi.org/10.1177/000348941011900506.
Tüz M, Doğru H, Uygur K, Gedikli O. Improvement in bone conduction threshold after tympanoplasty. Otolaryngol Head Neck Surg. 2000;123(6):775–8. https://doi.org/10.1067/mhn.2000.111292.
de Oliveira Penido N, Testa JR, Inoue DP, et al. Presentation, treatment, and clinical course of otogenic sigmoid sinus thrombophlebitis. Acta Otolaryngol. 2009;129(7):729–34. https://doi.org/10.1080/00016480802399721.
Bradley DT, Hashisaki GT, Mason JC. Otogenic sigmoid sinus thrombosis: what is the role of anticoagulation? Laryngoscope. 2002;112(10):1726–9. https://doi.org/10.1097/00005537-200210000-00003.
Acknowledgements
The work was supported by the Luzhou Science and Technology Bureau Social Development
Science and Technology Plan Project (Project number: 2021-SYF-30)
Funding
This study was funded by the Luzhou Science and Technology Bureau Social Development Science and Technology Plan Project (grant number: 2021-SYF-30).
Author information
Authors and Affiliations
Contributions
JF: Summarize, data analysis and paper writing; XP: Provide analysis of the subject and assist in editing the paper; TY: Clinical data collection and paper writing; XS: Clinical data collection and data statistics; LG: Clinical data collection and data statistics; NL: study design; LL: study design and manuscript review.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). Individual consent for this retrospective analysis was waived. The study was approved by the ethics committee of the Affiliated Hospital of Southwest Medical University. (No. KY2022311).
Consent for publication
All individuals signed a written consent for data processing.
Competing interests
The authors declare that they have no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Fei, J., Peng, XW., Yang, TY. et al. Experience in the management of sigmoid sinus thrombophlebitis secondary to middle ear cholesteatoma. J of Otolaryngol - Head & Neck Surg 52, 84 (2023). https://doi.org/10.1186/s40463-023-00681-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40463-023-00681-2